Fig. 2From: Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective studyOutcomes of patients with immune-mediated thrombotic thrombocytopenic purpura. a. Cumulative incidence of a clinical response. b. Cumulative incidence of clinical remission. c. Cumulative incidence of survival. iTTP, immune-mediated TTP; SLE, systemic lupus erythematosus; TTP, thrombotic thrombocytopenic purpuraBack to article page